Search results for: 'CleanCap® AG analog'

Search results in other pages:

catalogsearch_fulltext

CleanCap^® beta gal mRNA

Cat #: L-7608
catalogsearch_fulltext

CleanCap^® FLuc mRNA

Cat #: L-7602
catalogsearch_fulltext

CleanCap^® Cas9 mRNA (5moU)

Cat #: L-7206
catalogsearch_fulltext

CleanCap^® EGFP mRNA

Cat #: L-7601
catalogsearch_fulltext

CleanCap^® Renilla Luc mRNA (5moU)

Cat #: L-7204
catalogsearch_fulltext

CleanCap^® beta gal mRNA (5moU)

Cat #: L-7208
catalogsearch_fulltext

CleanCap^® mCherry mRNA (5moU)

Cat #: L-7203
catalogsearch_fulltext

CleanCap^® FLuc mRNA (5moU)

Cat #: L-7202
catalogsearch_fulltext

CleanCap^® EGFP mRNA (5moU)

Cat #: L-7201
maravai_services

“minRNA”—mRNAs with minimalistic untranslated regions (UTRs) are highly functional In Vitro and In Vivo

Introduction Synthetic mRNA produced by in vitro transcription (IVT) is the active pharmaceutical ingredient of approved vaccines and of many drugs under development. IVT mRNA typically contains several hundred bases of non-coding untranslated regions (UTRs) that are involved in the stabilization and translation of the mRNA. Remarkably, new research has discovered that these UTRs can be virtually eliminated without compromising translation of the encoded protein of interest. ...